Literature DB >> 2583869

Phenotypic and cytogenetic characterization of a cell line derived from primary prostatic carcinoma.

A R Brothman1, L J Lesho, K D Somers, G L Wright, D J Merchant.   

Abstract

A new cell line, PPC-I, has been established from a specimen obtained from a patient with a poorly differentiated adenocarcinoma of the prostate. This is the first line of its type derived from a primary prostatic tumor site. PPC-I cells have become immortalized in culture, exhibit transformation parameters including relaxed growth factor requirements and anchorage-independent growth, and are highly tumorigenic in nude mice. Cytogenetic studies by G-banding revealed a grossly abnormal karyotype, with a modal chromosome number of 84, multiple marker chromosomes including both homogeneously staining regions and double minutes and clonal loss of chromosomes 3, 5, 10, 15 and Y.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583869     DOI: 10.1002/ijc.2910440525

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  LNCaP-OM, a new androgen-resistant prostate cancer subline.

Authors:  M Platica; R S Verma; M J Macera; O Platica
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-03       Impact factor: 2.416

2.  A better defined medium for human prostate cancer cells.

Authors:  T G Pretlow; G S Ogrinc; S B Amini; C M Delmoro; K F Molkentin; J K Willson; T P Pretlow
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-07       Impact factor: 2.416

Review 3.  Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis.

Authors:  L Y Bourrguignon; N Iida; C F Welsh; D Zhu; A Krongrad; D Pasquale
Journal:  J Neurooncol       Date:  1995-12       Impact factor: 4.130

4.  Endothelin-1 inhibits apoptosis in prostate cancer.

Authors:  Joel B Nelson; Michael S Udan; Georgi Guruli; Beth R Pflug
Journal:  Neoplasia       Date:  2005-07       Impact factor: 5.715

5.  Acid ceramidase-mediated production of sphingosine 1-phosphate promotes prostate cancer invasion through upregulation of cathepsin B.

Authors:  Thomas H Beckham; Ping Lu; Joseph C Cheng; Dan Zhao; Lorianne S Turner; Xiaoyi Zhang; Stanley Hoffman; Kent E Armeson; Angen Liu; Tucker Marrison; Yusuf A Hannun; Xiang Liu
Journal:  Int J Cancer       Date:  2012-03-27       Impact factor: 7.396

6.  Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.

Authors:  W H Lee; R A Morton; J I Epstein; J D Brooks; P A Campbell; G S Bova; W S Hsieh; W B Isaacs; W G Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

7.  Detection by DNA fingerprinting of somatic changes during the establishment of a new prostate cell line.

Authors:  P D van Helden; I J Wiid; E G Hoal-van Helden; E Bey; R Cohen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

8.  Autophagy is increased in prostate cancer cells overexpressing acid ceramidase and enhances resistance to C6 ceramide.

Authors:  L S Turner; J C Cheng; T H Beckham; T E Keane; J S Norris; X Liu
Journal:  Prostate Cancer Prostatic Dis       Date:  2010-11-30       Impact factor: 5.554

9.  The Arf-like GTPase Arl8b is essential for three-dimensional invasive growth of prostate cancer in vitro and xenograft formation and growth in vivo.

Authors:  Samantha S Dykes; Alana L Gray; David T Coleman; Madhurima Saxena; Charles A Stephens; Jennifer L Carroll; Kevin Pruitt; James A Cardelli
Journal:  Oncotarget       Date:  2016-05-24

10.  Promoter methylation of TSLC1 and tumor suppression by its gene product in human prostate cancer.

Authors:  Hiroshi Fukuhara; Masami Kuramochi; Takeshi Fukami; Kohtaro Kasahara; Mutsuo Furuhata; Takahiro Nobukuni; Tomoko Maruyama; Kana Isogai; Takao Sekiya; Taro Shuin; Tadaichi Kitamura; Roger H Reeves; Yoshinori Murakami
Journal:  Jpn J Cancer Res       Date:  2002-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.